My understanding is that 25-30% profit with most of the US sales going through the WIC programme is very optimistic - maybe 5% at best?
My educated guess is that A2M management haven’t been asleep at the wheel but made an offer under the FDA exemption to supply a limited number of tins at a minimum margin. They would surely rather direct product to the high margin China market at this point while keeping a door open in the US but under specific terms.
Of course they could all be out playing golf but I think the former is more likely. Come Aug 29th I guess we’ll know more!
Ann: Deferral of FDA consideration of enforcement discretion, page-103
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.93 |
Change
-0.080(1.14%) |
Mkt cap ! $5.009B | |||
| Open | High | Low | Value | Volume |
| $6.99 | $7.02 | $6.89 | $14.18M | 2.042M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 26329 | $6.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.94 | 23537 | 4 |
View Market Depth
| Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$6.90 |
Change
-0.080 ( 1.39 %) |
||||
| Open | High | Low | Volume | ||
| $7.00 | $7.03 | $6.89 | 812253 | ||
| Last updated 15.59pm 30/05/2024 ? | |||||
| A2M (ASX) Chart |